STRYKER CORP Current Income Tax Expense (Benefit)
STRYKER CORP (SYK) reported Current Income Tax Expense (Benefit) of $876.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-11
- STRYKER CORP current income tax expense (benefit) for fiscal 2025 was $876.00M, a 0.81% increase from fiscal 2024.
- STRYKER CORP current income tax expense (benefit) for fiscal 2024 was $869.00M, a 21.71% increase from fiscal 2023.
- STRYKER CORP current income tax expense (benefit) for fiscal 2023 was $714.00M, a 167.42% increase from fiscal 2022.
- STRYKER CORP current income tax expense (benefit) for fiscal 2022 was $267.00M, a 49.05% decline from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $876.00M 10-K · filed 2026-02-11 | |
| 2024-12-31 | $869.00M 10-K · filed 2026-02-11 | |
| 2023-12-31 | $714.00M 10-K · filed 2026-02-11 | |
| 2022-12-31 | $267.00M 10-K · filed 2025-02-12 | |
| 2021-12-31 | $524.00M 10-K · filed 2024-02-14 | |
| 2020-12-31 | $307.00M 10-K · filed 2023-02-10 | |
| 2019-12-31 | $353.00M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $385.00M 10-K · filed 2021-02-11 | |
| 2017-12-31 | $1.01B 10-K · filed 2020-02-06 | |
| 2016-12-31 | $320.00M 10-K · filed 2019-02-07 | |
| 2015-12-31 | $209.00M 10-K · filed 2018-02-08 | |
| 2014-12-31 | $585.00M 10-K · filed 2017-02-09 | |
| 2013-12-31 | $183.00M 10-K · filed 2016-02-11 | |
| 2012-12-31 | $446.00M 10-K · filed 2015-02-12 | |
| 2011-12-31 | $505.00M 10-K · filed 2014-02-13 | |
| 2010-12-31 | $560.00M 10-K · filed 2013-02-27 | |
| 2009-12-31 | $589.00M 10-K · filed 2012-02-13 | $589.20M 10-K · filed 2011-02-18 |
| 2008-12-31 | $450.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |